FUNDC2P1

Across TCGA pan-cancer cohorts, FUNDC2P1 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated FUNDC2P1 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher FUNDC2P1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated FUNDC2P1 expression acts as an unfavorable survival marker, although some lineages such as MESO and BLCA show a favorable association.

MESO, UVM, and LIHC are the cancer types where FUNDC2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Quartile	All	0.659	0.294	<.001	91	view →
UVM	DFS	Tertile	III,IV	0.272	0.830	<.001	72	view →
LIHC	OS	Median	All	0.692	0.861	<.001	54	view →
BLCA	OS	Quartile	IV	0.810	0.483	.001	33	view →
UCEC	DFS	Tertile	All	0.614	0.812	.001	32	view →
HNSC	DFS	Quartile	II,III,IV	0.594	0.755	.004	29	view →
BRCA	OS	Quartile	III,IV	0.841	0.547	<.001	21	view →
KIRC	DFS	Quartile	II,III,IV	0.753	0.529	.008	20	view →
CHOL	OS	Tertile	All	0.382	0.779	.015	19	view →
LGG	DFS	Tertile	All	0.650	0.393	.001	17	view →
KICH	DFS	Median	II,III,IV	0.728	0.956	.021	14	view →
COAD	OS	Tertile	II,III,IV	0.930	0.762	.020	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

FUNDC2P1–MESO (OS)

Open the MESO breakdown →